Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editor's pick

22-10-2019 | Juvenile idiopathic arthritis | Highlight | News

Etanercept not linked to uveitis risk in real-world JIA study

An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.

18-10-2019 | Psoriatic arthritis | Podcast | Article

Discussing the guidelines for managing psoriatic arthritis: Part 1

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.

11-10-2019 | Axial spondyloarthritis | Editorial | Article

Do current therapies slow radiographic progression in axial spondyloarthritis/ ankylosing spondylitis?

Preston Le, Stephanie Qi, and Liron Caplan discuss the efficacy of current therapies in slowing radiographic progression of ankylosing spondylitis.

2019 ACR/ARP Annual Meeting Highlights

Visit the conference hub for clinical trial overviews and session recommendations. Atlanta, USA, November 10–13.

Latest from across the site

22-10-2019 | Juvenile idiopathic arthritis | Highlight | News

Etanercept not linked to uveitis risk in real-world JIA study

An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.

21-10-2019 | Gout | News

Achieving target sUA levels ‘should be a principal goal’ in hyperuricemic patients with gout

People with gout and hyperuricemia who achieve guideline-recommended serum uric acid levels below 0.36 mmol/L have lower risks for overall and cardiovascular mortality than those who do not meet this target, researchers report.

18-10-2019 | Rheumatoid arthritis | News

Upadacitinib recommended for European approval

Click through for more information

18-10-2019 | Arthroplasty | News

Social support may improve some outcomes after joint replacement

Findings from a systematic review and meta-analysis indicate that social support may have a beneficial effect on some outcomes after knee or hip replacement surgery.

18-10-2019 | Psoriatic arthritis | Podcast | Article

Discussing the guidelines for managing psoriatic arthritis: Part 1

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.

17-10-2019 | Rheumatoid arthritis | News

Treatment switching associated with VTE risk in RA

People with rheumatoid arthritis who switch between different biologic or targeted synthetic DMARDs have a higher risk for venous thromboembolism than those who remain on the same treatment, researchers report.

Latest from us on Twitter

Trending this week

Meet our Editorial Board

New Content Item Meet our Advisory Board

Image Credits